Literature DB >> 3403314

Radiotherapy in the treatment of pituitary adenomas.

M Chun1, G B Masko, S Hetelekidis.   

Abstract

Between 1970 and 1985, 145 patients were treated for pituitary adenomas and 126 patients were available for analysis. Sixty patients were treated with surgery alone (Group I), 54 were treated with surgery and radiation therapy (Group II), and 12 received irradiation only without tissue diagnosis (Group III). Extent of tumor was evaluated by CT scan, PEG, and surgical reports. There were 22 microadenomas in Group I and only 1 microadenoma in Group II. The mean follow-up was 6.4 years, 85% (51/60) of patients in Group I, 93% of patients in Group II, and only 50% of those treated with irradiation alone achieved tumor control. With subsequent salvage treatment, overall tumor control in Group I was 97%. The mean time to recurrence was 3.7 years (Group I), 4.5 years (Group II), and 4 years (Group III). In summary, combined treatment is effective to decrease the chance of local recurrence of pituitary adenomas. Nevertheless, because of successful salvage treatment after surgical failure, overall outcome is similar. Without persistent symptom after surgery or large residual tumor in or near the critical structures, postoperative irradiation can be deferred until tumor regrowth.

Entities:  

Mesh:

Year:  1988        PMID: 3403314     DOI: 10.1016/s0360-3016(98)90009-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts.

Authors:  M Shibuya; F Saito; T Miwa; R L Davis; C B Wilson; T Hoshino
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Delayed radiation necrosis of the central nervous system in patients irradiated for pituitary tumours.

Authors:  P J Grattan-Smith; J G Morris; A O Langlands
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

3.  Experience in management of 51 non-functioning pituitary adenomas: indications for post-operative radiotherapy.

Authors:  C Alameda; T Lucas; E Pineda; M Brito; J G Uría; R Magallón; J Estrada; B Barceló
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

4.  Telomerase activity in pituitary adenomas: significance of telomerase expression in predicting pituitary adenoma recurrence.

Authors:  Atsuo Yoshino; Yoichi Katayama; Takao Fukushima; Takao Watanabe; Chiaki Komine; Takakazu Yokoyama; Kaoru Kusama; Itaru Moro
Journal:  J Neurooncol       Date:  2003-06       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.